Reactive Markets, a leading provider of high-performance Over-the-Counter (OTC) execution solutions, announced the promotion of Henry Durrant to the position of Chief Revenue Officer (CRO). In his new role, Henry will drive the company’s revenue growth strategy, overseeing the expansion of Reactive Markets’ client base and maximizing the potential of its innovative trading solutions.
Henry Durrant has been an integral part of the Reactive Markets team, playing a key role in the company’s success by focusing on delivering the highest-quality execution services to its clients. With a strong background in business development and revenue generation, Henry brings a wealth of expertise to his new role as CRO.
Over the years, Henry has demonstrated his ability to forge strong relationships with clients and partners, ensuring that Reactive Markets continues to offer the most competitive pricing, exceptional fill rates, and a platform that meets the dynamic needs of OTC traders.
Reactive Markets provides cutting-edge OTC execution solutions designed to help clients navigate the complexities of the financial markets with ease and efficiency. With a focus on delivering the tightest pricing and the highest fill rates, the company has earned a reputation for offering a reliable, high-performance platform backed by exceptional customer service.
One of Reactive Markets’ key offerings is its fully disclosed bi-lateral streaming service, Switchboard. This service enables clients to connect directly to over 20 of the top liquidity providers in the industry, including all of the top 10 Euromoney Liquidity Providers. Additionally, the platform supports a diverse blend of banks, non-banks, and regional specialists, providing a comprehensive range of Spot FX, NDFs, and Forwards.
With Henry Durrant now serving as Chief Revenue Officer, Reactive Markets is poised for continued growth. His leadership will help drive the company’s strategic objectives as it expands its global footprint, strengthens client relationships, and innovates within the competitive OTC execution space.